PDB Short entry for 1PYO HEADER HYDROLASE/HYDROLASE INHIBITOR 09-JUL-03 1PYO TITLE CRYSTAL STRUCTURE OF HUMAN CASPASE-2 IN COMPLEX WITH ACETYL-LEU-ASP- TITLE 2 GLU-SER-ASP-CHO COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-2; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: SUBUNIT P18, SEQUENCE DATABASE RESIDUES 151-316; COMPND 5 SYNONYM: CASP-2, ICH-1 PROTEASE, ICH- 1L/1S; COMPND 6 EC: 3.4.22.-; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CASPASE-2; COMPND 10 CHAIN: B, D; COMPND 11 FRAGMENT: SUBUNIT P12, SEQUENCE DATABASE RESIDUES 331-435; COMPND 12 SYNONYM: CASP-2, ICH-1 PROTEASE, ICH- 1L/1S; COMPND 13 EC: 3.4.22.-; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: ACETYL-LEU-ASP-GLU-SER-ASJ; COMPND 17 CHAIN: E, F; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP2 OR ICH1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS(DE3)-RIL (STRATAGENE); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11D; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: CASP2 OR ICH1; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS(DE3)-RIL (STRATAGENE); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET11D; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE (BAKER'S YEAST); SOURCE 24 ORGANISM_TAXID: 559292; SOURCE 25 OTHER_DETAILS: SYNTHETIC, FROM CALBIOCHEM KEYWDS APOPTOSIS, CASPASE, ALPHA-BETA, THIOL PROTEASE, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.SCHWEIZER,C.BRIAND,M.G.GRUTTER REVDAT 7 15-NOV-23 1PYO 1 REMARK REVDAT 6 16-AUG-23 1PYO 1 SEQADV LINK REVDAT 5 03-JUL-13 1PYO 1 HET HETATM HETNAM REMARK REVDAT 5 2 1 SEQRES REVDAT 4 13-JUL-11 1PYO 1 VERSN REVDAT 3 24-FEB-09 1PYO 1 VERSN REVDAT 2 18-NOV-03 1PYO 1 JRNL REMARK COMPND DBREF REVDAT 1 26-AUG-03 1PYO 0 JRNL AUTH A.SCHWEIZER,C.BRIAND,M.G.GRUTTER JRNL TITL CRYSTAL STRUCTURE OF CASPASE-2, APICAL INITIATOR OF THE JRNL TITL 2 INTRINSIC APOPTOTIC PATHWAY. JRNL REF J.BIOL.CHEM. V. 278 42441 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12920126 JRNL DOI 10.1074/JBC.M304895200 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 72998 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1474 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.67 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2814 REMARK 3 BIN FREE R VALUE : 0.2662 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 40 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4181 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 385 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.93 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.22000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : -2.50000 REMARK 3 B13 (A**2) : 2.28000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.595 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.020 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1PYO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JUL-03. REMARK 100 THE DEPOSITION ID IS D_1000019703. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-FEB-03 REMARK 200 TEMPERATURE (KELVIN) : 90 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : SI(111) CRYSTAL REMARK 200 OPTICS : DYNAMICALLY BENDABLE MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74129 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.1400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.71 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.47600 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.030 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1CP3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, MOPS, DTT, SUCROSE, PH 7.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.82450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.77350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.29150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.77350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.82450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.29150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 18000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -88.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, C, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THERE IS A COVALENT BOND BETWEEN ATOM SG OF CYS155 OF CHAIN A/C AND REMARK 400 ATOM C OF ASA406 OF CHAIN E/F, FORMING THIOHEMIACETAL REMARK 400 REMARK 400 THE N-ACETYL-L-LEUCYL-L-ALPHA-ASPARTYL-L-ALPHA-GLUTAMYL-L-SERYL-L- REMARK 400 ASPARTIC ALDEHYDE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-ACETYL-L-LEUCYL-L-ALPHA-ASPARTYL-L-ALPHA-GLUTAMYL-L-SERYL- REMARK 400 L-ASPARTIC ALDEHYDE REMARK 400 CHAIN: E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 2 REMARK 465 LYS A 3 REMARK 465 ASP A 4 REMARK 465 GLY A 5 REMARK 465 PRO A 6 REMARK 465 VAL A 7 REMARK 465 CYS A 8 REMARK 465 ASP A 168 REMARK 465 ALA B 201 REMARK 465 GLY B 202 REMARK 465 LYS B 203 REMARK 465 GLU B 204 REMARK 465 LYS B 205 REMARK 465 LEU B 206 REMARK 465 THR B 305 REMARK 465 ASN C 2 REMARK 465 LYS C 3 REMARK 465 ASP C 4 REMARK 465 GLY C 5 REMARK 465 PRO C 6 REMARK 465 VAL C 7 REMARK 465 ALA D 201 REMARK 465 GLY D 202 REMARK 465 LYS D 203 REMARK 465 GLU D 204 REMARK 465 LYS D 205 REMARK 465 LEU D 206 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 14 CA - CB - SG ANGL. DEV. = 7.9 DEGREES REMARK 500 ACE E 401 O - C - N ANGL. DEV. = 10.0 DEGREES REMARK 500 SER E 405 O - C - N ANGL. DEV. = -9.6 DEGREES REMARK 500 ASJ E 406 C - N - CA ANGL. DEV. = 19.4 DEGREES REMARK 500 ACE F 401 O - C - N ANGL. DEV. = 10.3 DEGREES REMARK 500 SER F 405 O - C - N ANGL. DEV. = -10.3 DEGREES REMARK 500 ASJ F 406 C - N - CA ANGL. DEV. = 17.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 29 76.21 -154.80 REMARK 500 PHE A 45 -125.05 -117.93 REMARK 500 THR A 46 103.43 82.64 REMARK 500 LYS A 49 -12.69 51.68 REMARK 500 SER A 111 -170.12 -177.18 REMARK 500 ASP B 253 14.53 -145.59 REMARK 500 ALA B 274 64.10 -170.40 REMARK 500 LEU C 29 77.66 -151.93 REMARK 500 ASP C 80 70.41 45.22 REMARK 500 SER C 111 -169.95 -174.49 REMARK 500 ALA C 154 149.28 -170.48 REMARK 500 LYS D 208 115.83 80.35 REMARK 500 ASP D 253 16.51 -145.11 REMARK 500 ALA D 274 61.23 -170.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF RESIDUES 401 TO 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF RESIDUES 401 TO 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF ACETYL-LEU-ASP-GLU REMARK 800 -SER-ASJ REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF ACETYL-LEU-ASP-GLU REMARK 800 -SER-ASJ REMARK 999 REMARK 999 SEQUENCE REMARK 999 CHAINS E AND F REPRESENT A SYNTHETIC SEQUENCE REMARK 999 THAT IS COMMONLY USED FOR SUBSTRATES AND REMARK 999 INHIBITORS FOR CASPASE-2 DBREF 1PYO A 2 168 UNP P42575 CASP2_HUMAN 167 333 DBREF 1PYO B 201 305 UNP P42575 CASP2_HUMAN 348 452 DBREF 1PYO E 402 406 UNP P36114 YKZ8_YEAST 54 58 DBREF 1PYO C 2 168 UNP P42575 CASP2_HUMAN 167 333 DBREF 1PYO D 201 305 UNP P42575 CASP2_HUMAN 348 452 DBREF 1PYO F 402 406 UNP P36114 YKZ8_YEAST 54 58 SEQADV 1PYO ACE E 401 UNP P36114 INSERTION SEQADV 1PYO ACE F 401 UNP P36114 INSERTION SEQRES 1 A 167 ASN LYS ASP GLY PRO VAL CYS LEU GLN VAL LYS PRO CYS SEQRES 2 A 167 THR PRO GLU PHE TYR GLN THR HIS PHE GLN LEU ALA TYR SEQRES 3 A 167 ARG LEU GLN SER ARG PRO ARG GLY LEU ALA LEU VAL LEU SEQRES 4 A 167 SER ASN VAL HIS PHE THR GLY GLU LYS GLU LEU GLU PHE SEQRES 5 A 167 ARG SER GLY GLY ASP VAL ASP HIS SER THR LEU VAL THR SEQRES 6 A 167 LEU PHE LYS LEU LEU GLY TYR ASP VAL HIS VAL LEU CYS SEQRES 7 A 167 ASP GLN THR ALA GLN GLU MET GLN GLU LYS LEU GLN ASN SEQRES 8 A 167 PHE ALA GLN LEU PRO ALA HIS ARG VAL THR ASP SER CYS SEQRES 9 A 167 ILE VAL ALA LEU LEU SER HIS GLY VAL GLU GLY ALA ILE SEQRES 10 A 167 TYR GLY VAL ASP GLY LYS LEU LEU GLN LEU GLN GLU VAL SEQRES 11 A 167 PHE GLN LEU PHE ASP ASN ALA ASN CYS PRO SER LEU GLN SEQRES 12 A 167 ASN LYS PRO LYS MET PHE PHE ILE GLN ALA CYS ARG GLY SEQRES 13 A 167 ASP GLU THR ASP ARG GLY VAL ASP GLN GLN ASP SEQRES 1 B 105 ALA GLY LYS GLU LYS LEU PRO LYS MET ARG LEU PRO THR SEQRES 2 B 105 ARG SER ASP MET ILE CYS GLY TYR ALA CYS LEU LYS GLY SEQRES 3 B 105 THR ALA ALA MET ARG ASN THR LYS ARG GLY SER TRP TYR SEQRES 4 B 105 ILE GLU ALA LEU ALA GLN VAL PHE SER GLU ARG ALA CYS SEQRES 5 B 105 ASP MET HIS VAL ALA ASP MET LEU VAL LYS VAL ASN ALA SEQRES 6 B 105 LEU ILE LYS ASP ARG GLU GLY TYR ALA PRO GLY THR GLU SEQRES 7 B 105 PHE HIS ARG CYS LYS GLU MET SER GLU TYR CYS SER THR SEQRES 8 B 105 LEU CYS ARG HIS LEU TYR LEU PHE PRO GLY HIS PRO PRO SEQRES 9 B 105 THR SEQRES 1 E 6 ACE LEU ASP GLU SER ASJ SEQRES 1 C 167 ASN LYS ASP GLY PRO VAL CYS LEU GLN VAL LYS PRO CYS SEQRES 2 C 167 THR PRO GLU PHE TYR GLN THR HIS PHE GLN LEU ALA TYR SEQRES 3 C 167 ARG LEU GLN SER ARG PRO ARG GLY LEU ALA LEU VAL LEU SEQRES 4 C 167 SER ASN VAL HIS PHE THR GLY GLU LYS GLU LEU GLU PHE SEQRES 5 C 167 ARG SER GLY GLY ASP VAL ASP HIS SER THR LEU VAL THR SEQRES 6 C 167 LEU PHE LYS LEU LEU GLY TYR ASP VAL HIS VAL LEU CYS SEQRES 7 C 167 ASP GLN THR ALA GLN GLU MET GLN GLU LYS LEU GLN ASN SEQRES 8 C 167 PHE ALA GLN LEU PRO ALA HIS ARG VAL THR ASP SER CYS SEQRES 9 C 167 ILE VAL ALA LEU LEU SER HIS GLY VAL GLU GLY ALA ILE SEQRES 10 C 167 TYR GLY VAL ASP GLY LYS LEU LEU GLN LEU GLN GLU VAL SEQRES 11 C 167 PHE GLN LEU PHE ASP ASN ALA ASN CYS PRO SER LEU GLN SEQRES 12 C 167 ASN LYS PRO LYS MET PHE PHE ILE GLN ALA CYS ARG GLY SEQRES 13 C 167 ASP GLU THR ASP ARG GLY VAL ASP GLN GLN ASP SEQRES 1 D 105 ALA GLY LYS GLU LYS LEU PRO LYS MET ARG LEU PRO THR SEQRES 2 D 105 ARG SER ASP MET ILE CYS GLY TYR ALA CYS LEU LYS GLY SEQRES 3 D 105 THR ALA ALA MET ARG ASN THR LYS ARG GLY SER TRP TYR SEQRES 4 D 105 ILE GLU ALA LEU ALA GLN VAL PHE SER GLU ARG ALA CYS SEQRES 5 D 105 ASP MET HIS VAL ALA ASP MET LEU VAL LYS VAL ASN ALA SEQRES 6 D 105 LEU ILE LYS ASP ARG GLU GLY TYR ALA PRO GLY THR GLU SEQRES 7 D 105 PHE HIS ARG CYS LYS GLU MET SER GLU TYR CYS SER THR SEQRES 8 D 105 LEU CYS ARG HIS LEU TYR LEU PHE PRO GLY HIS PRO PRO SEQRES 9 D 105 THR SEQRES 1 F 6 ACE LEU ASP GLU SER ASJ HET ACE E 401 3 HET ASJ E 406 8 HET ACE F 401 3 HET ASJ F 406 8 HETNAM ACE ACETYL GROUP HETNAM ASJ (3S)-3-AMINO-4-HYDROXYBUTANOIC ACID FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 ASJ 2(C4 H9 N O3) FORMUL 7 HOH *385(H2 O) HELIX 1 1 THR A 15 PHE A 23 1 9 HELIX 2 2 GLN A 24 ALA A 26 5 3 HELIX 3 3 GLY A 56 LEU A 71 1 16 HELIX 4 4 THR A 82 GLN A 95 1 14 HELIX 5 5 LEU A 96 VAL A 101 5 6 HELIX 6 6 LEU A 128 PHE A 135 1 8 HELIX 7 7 CYS A 140 GLN A 144 5 5 HELIX 8 8 TRP B 238 ALA B 251 1 14 HELIX 9 9 HIS B 255 ASP B 269 1 15 HELIX 10 10 THR C 15 PHE C 23 1 9 HELIX 11 11 GLN C 24 ALA C 26 5 3 HELIX 12 12 GLY C 56 LEU C 71 1 16 HELIX 13 13 THR C 82 GLN C 95 1 14 HELIX 14 14 LEU C 96 THR C 102 5 7 HELIX 15 15 LEU C 128 PHE C 135 1 8 HELIX 16 16 CYS C 140 GLN C 144 5 5 HELIX 17 17 TRP D 238 ALA D 251 1 14 HELIX 18 18 HIS D 255 ARG D 270 1 16 SHEET 1 A12 TYR A 73 CYS A 79 0 SHEET 2 A12 GLY A 35 SER A 41 1 N ALA A 37 O HIS A 76 SHEET 3 A12 SER A 104 LEU A 110 1 O ALA A 108 N LEU A 38 SHEET 4 A12 LYS A 148 GLN A 153 1 O MET A 149 N CYS A 105 SHEET 5 A12 MET B 217 TYR B 221 1 O GLY B 220 N ILE A 152 SHEET 6 A12 GLU B 287 SER B 290 -1 O GLU B 287 N TYR B 221 SHEET 7 A12 GLU D 287 SER D 290 -1 O TYR D 288 N SER B 290 SHEET 8 A12 MET D 217 TYR D 221 -1 N TYR D 221 O GLU D 287 SHEET 9 A12 LYS C 148 GLN C 153 1 N ILE C 152 O GLY D 220 SHEET 10 A12 SER C 104 LEU C 110 1 N CYS C 105 O MET C 149 SHEET 11 A12 GLY C 35 SER C 41 1 N LEU C 40 O LEU C 110 SHEET 12 A12 TYR C 73 CYS C 79 1 O HIS C 76 N ALA C 37 SHEET 1 B 3 GLY A 113 VAL A 114 0 SHEET 2 B 3 ALA A 117 TYR A 119 -1 O ALA A 117 N VAL A 114 SHEET 3 B 3 LEU A 125 GLN A 127 -1 O LEU A 126 N ILE A 118 SHEET 1 C 2 VAL A 164 ASP A 165 0 SHEET 2 C 2 ARG D 210 LEU D 211 -1 O LEU D 211 N VAL A 164 SHEET 1 D 2 ARG B 210 LEU B 211 0 SHEET 2 D 2 VAL C 164 ASP C 165 -1 O VAL C 164 N LEU B 211 SHEET 1 E 3 GLY B 236 SER B 237 0 SHEET 2 E 3 MET B 230 ASN B 232 -1 N ASN B 232 O GLY B 236 SHEET 3 E 3 ASP E 403 SER E 405 -1 O GLU E 404 N ARG B 231 SHEET 1 F 3 GLY C 113 VAL C 114 0 SHEET 2 F 3 ALA C 117 TYR C 119 -1 O ALA C 117 N VAL C 114 SHEET 3 F 3 LEU C 125 GLN C 127 -1 O LEU C 126 N ILE C 118 SHEET 1 G 3 GLY D 236 SER D 237 0 SHEET 2 G 3 MET D 230 ASN D 232 -1 N ASN D 232 O GLY D 236 SHEET 3 G 3 ASP F 403 SER F 405 -1 O GLU F 404 N ARG D 231 SSBOND 1 CYS B 289 CYS D 289 1555 1555 2.08 LINK SG CYS A 155 C ASJ E 406 1555 1555 1.76 LINK C ACE E 401 N LEU E 402 1555 1555 1.25 LINK C SER E 405 N ASJ E 406 1555 1555 1.44 LINK SG CYS C 155 C ASJ F 406 1555 1555 1.77 LINK C ACE F 401 N LEU F 402 1555 1555 1.25 LINK C SER F 405 N ASJ F 406 1555 1555 1.42 CISPEP 1 ARG A 32 PRO A 33 0 0.14 CISPEP 2 HIS B 302 PRO B 303 0 -0.12 CISPEP 3 ARG C 32 PRO C 33 0 -0.06 CISPEP 4 HIS D 302 PRO D 303 0 -0.48 SITE 1 AC1 4 ASN B 232 THR B 233 TYR B 273 LEU E 402 SITE 1 AC2 5 ASP B 269 ASN D 232 THR D 233 LYS D 234 SITE 2 AC2 5 LEU F 402 SITE 1 AC3 18 ARG A 54 HIS A 112 GLY A 113 GLN A 153 SITE 2 AC3 18 CYS A 155 ALA B 228 ALA B 229 MET B 230 SITE 3 AC3 18 ARG B 231 ASN B 232 THR B 233 TRP B 238 SITE 4 AC3 18 GLY B 272 TYR B 273 ALA B 274 PHE B 279 SITE 5 AC3 18 HOH B 345 HOH E 383 SITE 1 AC4 21 GLN C 24 ARG C 54 HIS C 112 GLY C 113 SITE 2 AC4 21 GLN C 153 CYS C 155 HOH C 240 ALA D 229 SITE 3 AC4 21 MET D 230 ARG D 231 ASN D 232 THR D 233 SITE 4 AC4 21 TRP D 238 GLY D 272 TYR D 273 PHE D 279 SITE 5 AC4 21 ARG D 294 HOH F 167 HOH F 220 HOH F 252 SITE 6 AC4 21 HOH F 266 CRYST1 63.649 96.583 97.547 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015711 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010354 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010251 0.00000